Parsippany, New Jersey. Edenbridge Pharmaceuticals, LLC is pleased to announce the launch of Vigabatrin Tablets USP, 500mg, a generic version of Sabril®* Tablets, 500mg. Vigabatrin Tablets USP, 500mg are indicated as adjunctive therapy for refractory complex partial seizures in patients 2 years of age and older and as monotherapy for infantile spasms in infants 1 month to 2 years of age. Vigabatrin Tablets USP, 500mg are available through our preferred pharmacy partner, Orsini Specialty Pharmacy. For more information about Orsini Specialty Pharmacy and the support they can provide patients and their families please visit Orsini Specialty Pharmacy Patient Support.
Vigabatrin Tablets, USP Launch
Specialty Products
To learn more about our specialty products, vigabatrin and Yargesa®, and how you may be able to save, please visit the Products page or navigate to a product-specific page.
Specialty Products
To learn more about our specialty products, vigabatrin and Yargesa®, and how you may be able to save, please visit the Products page or navigate to a product-specific page.